BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31374134)

  • 1. Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Reimer A; Lu S; He Y; Bruckner-Tuderman L; Technau-Hafsi K; Meiss F; Has C; von Bubnoff D
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e1-e3. PubMed ID: 31374134
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.
    Kim M; Li M; Intong LR; Tran K; Melbourne W; Marucci D; Bucci J; de Souza P; Mallesara G; Murrell DF
    Br J Dermatol; 2013 Jul; 169(1):208-10. PubMed ID: 23398414
    [No Abstract]   [Full Text] [Related]  

  • 3. Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa.
    Piccerillo A; El Hachem M; De Vito R; De Luca EV; Peris K
    JAMA Dermatol; 2020 Jun; 156(6):708-710. PubMed ID: 32320041
    [No Abstract]   [Full Text] [Related]  

  • 4. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Vasilev P; Kalev D; Karamanliev M; Dimitrov D; Troyanova P; Yordanova I
    J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
    [No Abstract]   [Full Text] [Related]  

  • 5. Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.
    Medek K; Koelblinger P; Koller J; Diem A; Ude-Schoder K; Bauer JW; Laimer M
    J Dtsch Dermatol Ges; 2019 Apr; 17(4):448-450. PubMed ID: 30821421
    [No Abstract]   [Full Text] [Related]  

  • 6. Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.
    Ciurescu D; Condruz S; Irimie M
    Acta Dermatovenerol Alp Pannonica Adriat; 2024 May; 33(3):actaapa.2024.14. PubMed ID: 38808531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].
    Fourel E; Claudy AL
    Ann Dermatol Venereol; 1992; 119(8):563-5. PubMed ID: 1485760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa.
    Diociaiuti A; Steinke H; Nyström A; Schwieger-Briel A; Meiss F; Pfannenberg C; Bruckner-Tuderman L; Ruf J; De Vito R; El Hachem M; Kiritsi D
    Orphanet J Rare Dis; 2019 Dec; 14(1):278. PubMed ID: 31796084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases.
    Diociaiuti A; Rotunno R; El Hachem M; Latorre S; Cozza R; Curatolo P
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1195-6. PubMed ID: 25758658
    [No Abstract]   [Full Text] [Related]  

  • 10. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
    Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
    Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
    Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
    Newman C; Wagner RF; Tyring SK; Spigel GT
    J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient.
    Tomita Y; Sato-Matsumura KC; Sawamura D; Matsumura T; Shimizu H
    Acta Derm Venereol; 2003; 83(3):225-6. PubMed ID: 12816163
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
    Jacków J; Rami A; Hayashi R; Hansen C; Guo Z; DeLorenzo D; Pappalardo A; Alvarez Cespedes D; Kim AL; Perez-Lorenzo R; Owens DM; Christiano AM
    J Invest Dermatol; 2021 Apr; 141(4):942-946. PubMed ID: 33069729
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
    Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
    Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
    Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
    Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual plaque in a patient with recessive dystrophic epidermolysis bullosa.
    Zhu CS; Davis TL; Browning JC
    Pediatr Dermatol; 2021 Jul; 38(4):945-946. PubMed ID: 34448231
    [No Abstract]   [Full Text] [Related]  

  • 18. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
    Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
    Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
    Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
    J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
    [No Abstract]   [Full Text] [Related]  

  • 20. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
    Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
    Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.